PMC:7652766 / 98675-98915 JSONTXT

{"project":"LitCovid-sentences","denotations":[{"id":"T481","span":{"begin":0,"end":240},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The IFN group of COVID-19 patients (n=42) received IFN β-1a in addition to the protocol medications (hydroxychloroquine plus lopinavir-ritonavir or atazanavir-ritonavir) while the control group (n=39) received only the protocol medications."}

{"project":"LitCovid-PubTator","denotations":[{"id":"3620","span":{"begin":26,"end":34},"obj":"Species"},{"id":"3625","span":{"begin":4,"end":7},"obj":"Gene"},{"id":"3629","span":{"begin":101,"end":119},"obj":"Chemical"},{"id":"3630","span":{"begin":125,"end":144},"obj":"Chemical"},{"id":"3631","span":{"begin":148,"end":168},"obj":"Chemical"},{"id":"3634","span":{"begin":17,"end":25},"obj":"Disease"}],"attributes":[{"id":"A3620","pred":"tao:has_database_id","subj":"3620","obj":"Tax:9606"},{"id":"A3625","pred":"tao:has_database_id","subj":"3625","obj":"Gene:3439"},{"id":"A3629","pred":"tao:has_database_id","subj":"3629","obj":"MESH:D006886"},{"id":"A3630","pred":"tao:has_database_id","subj":"3630","obj":"MESH:C558899"},{"id":"A3634","pred":"tao:has_database_id","subj":"3634","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The IFN group of COVID-19 patients (n=42) received IFN β-1a in addition to the protocol medications (hydroxychloroquine plus lopinavir-ritonavir or atazanavir-ritonavir) while the control group (n=39) received only the protocol medications."}